Answers are grounded in this paper and cite their sources.
C/EBPα, -β, and -δ are members of the CCAAT/enhancer binding protein family of transcriptional regulators. All three of these factors are expressed by bone marrow-derived macrophages, with the DNA binding activity of C/EBPβ and -δ increased by treatment with LPS while that of C/EBPα is decreased. We have ectopically expressed each C/EBP protein in P388 lymphoblasts. The expression of any of these transcription factors is sufficient to confer the LPS-inducible expression of IL-6 and monocyte chemoattractant protein-1 to lymphoblasts, which normally lack C/EBP factors and do not display LPS induction of proinflammatory cytokines. Thus, the activities of C/EBPα, -β, and -δ are redundant in regard to the expression of IL-6 and monocyte chemoattractant protein-1. Since C/EBPβ-deficient mice have been reported to be largely normal in their expression of proinflammatory cytokines, it is likely that the lack of C/EBPβ is compensated for by the induction of C/EBPδ upon LPS treatment.
No takes yet. Share an insight, caveat, or question.
Hu et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: